0.75
price up icon2.70%   0.0197
 
loading
Precedente Chiudi:
$0.7303
Aprire:
$0.74
Volume 24 ore:
43,627
Relative Volume:
0.18
Capitalizzazione di mercato:
$77.99M
Reddito:
$1.29M
Utile/perdita netta:
$-29.87M
Rapporto P/E:
-2.0833
EPS:
-0.36
Flusso di cassa netto:
$-14.70M
1 W Prestazione:
+11.11%
1M Prestazione:
-1.32%
6M Prestazione:
+20.02%
1 anno Prestazione:
+8.70%
Intervallo 1D:
Value
$0.74
$0.75
Intervallo di 1 settimana:
Value
$0.68
$0.79
Portata 52W:
Value
$0.3951
$0.94

VolitionRX Ltd Stock (VNRX) Company Profile

Name
Nome
VolitionRX Ltd
Name
Telefono
646 650 1351
Name
Indirizzo
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Name
Dipendente
37
Name
Cinguettio
@VolitionRx
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
VNRX's Discussions on Twitter

Confronta VNRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
VNRX
VolitionRX Ltd
0.75 75.94M 1.29M -29.87M -14.70M -0.36
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
478.32 179.32B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
205.48 145.22B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
565.19 44.23B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
199.17 34.14B 15.50B 1.33B 2.16B 7.34
Diagnostics & Research icon
A
Agilent Technologies Inc
120.18 34.19B 6.63B 1.17B 1.19B 4.05

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-08 Iniziato H.C. Wainwright Buy
2023-02-01 Downgrade The Benchmark Company Buy → Hold
2022-02-17 Ripresa Cantor Fitzgerald Overweight
2021-03-10 Iniziato Cantor Fitzgerald Overweight
2018-05-16 Iniziato Maxim Group Buy
2018-05-14 Reiterato The Benchmark Company Buy
2016-09-07 Reiterato Rodman & Renshaw Buy
2016-02-01 Iniziato Rodman & Renshaw Buy
Mostra tutto

VolitionRX Ltd Borsa (VNRX) Ultime notizie

pulisher
Jul 25, 2025

How VolitionRx Limited stock performs during market volatilityFree Access to Community - Newser

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about VolitionRx Limited stockFree Stock Selection - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 22, 2025

VolitionRx Limited Stock Analysis and ForecastOutstanding capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about BGSF stockUnmatched profit growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why VolitionRx Limited stock attracts strong analyst attentionRisk Controlled Trading Ideas - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Is VolitionRx Limited a good long term investmentSky-high profits - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

What drives VolitionRx Limited stock pricePowerful profit generation - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 16, 2025

Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation - MarketScreener

Jul 16, 2025
pulisher
Jul 15, 2025

What makes VolitionRx Limited stock price move sharplyProven Win Setups - Newser

Jul 15, 2025
pulisher
Jul 08, 2025

VolitionRx Limited Announces Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Breakthrough: New 5-Minute Blood Test Could Transform Emergency Care and Sepsis Detection - Stock Titan

Jul 08, 2025
pulisher
Jul 08, 2025

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - Ariva

Jul 08, 2025
pulisher
Jul 02, 2025

VolitionRx:Nu.Q advances in lung cancer management - Research Tree

Jul 02, 2025
pulisher
Jun 27, 2025

VNRX INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of VolitionRx Ltd. (NYSE: VNRX) and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire

Jun 27, 2025
pulisher
Jun 16, 2025

VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock By Investing.com - Investing.com India

Jun 16, 2025
pulisher
Jun 16, 2025

VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock - Investing.com

Jun 16, 2025
pulisher
Jun 12, 2025

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1 Concentrations Are Closely Associated With Sepsis And Organ Failure - MarketScreener

Jun 12, 2025
pulisher
Jun 11, 2025

VolitionRx (NYSE:VNRX) Rating Increased to Strong-Buy at Jones Trading - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

VolitionRX (VNRX) Coverage Initiated with a 'Buy' Rating by Jones Trading | VNRX Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

JonesTrading Initiates Coverage on VolitionRx Limited With Buy Rating, $3 Price Target - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

This Yum! Brands Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga

Jun 10, 2025
pulisher
Jun 09, 2025

Jones Trading initiates VolitionRX with Buy, sets $3 target By Investing.com - Investing.com India

Jun 09, 2025
pulisher
Jun 09, 2025

VolitionRx (VNRX) Receives Buy Rating with Promising Price Targe - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

VolitionRx initiated with a Buy at JonesResearch - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

VolitionRx (VNRX) Receives Buy Rating with Promising Price Target | VNRX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 04, 2025

Director Makes Bold Move with Major VolitionRX Stock Purchase - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

VolitionRx director Guy Innes buys $10,772 in common stock By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

VolitionRx director Guy Innes buys $10,772 in common stock - Investing.com

Jun 04, 2025
pulisher
May 27, 2025

VNRX: Management's key financial goal for 2025 is to be cash neutral on a full year basis. - Research Tree

May 27, 2025
pulisher
May 27, 2025

VNRX: Management’s key financial goal for 2025 is to be cash neutral on a full year basis. Four operational milestones have been achieved thus far in 2025. Primary operational goal is to enter into multiple licensing agreements for human diagnostic applicati - Yahoo Finance

May 27, 2025
pulisher
May 20, 2025

VolitionRx Limited (AMEX:VNRX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 20, 2025
pulisher
May 19, 2025

VolitionRX Ltd. Earnings Call Reveals Promising Growth - TipRanks

May 19, 2025
pulisher
May 19, 2025

VolitionRX shares hold as Benchmark maintains rating - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

VNRX stock touches 52-week low at $0.42 amid market challenges - Investing.com Canada

May 19, 2025
pulisher
May 19, 2025

VolitionRX shares hold as Benchmark maintains rating By Investing.com - Investing.com India

May 19, 2025
pulisher
May 19, 2025

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats - Yahoo Finance

May 19, 2025
pulisher
May 19, 2025

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats By Investing.com - Investing.com Canada

May 19, 2025
pulisher
May 17, 2025

VolitionRX Ltd (VNRX) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones - Yahoo Finance

May 17, 2025
pulisher
May 17, 2025

VolitionRx Reports Strong Q1 2025 Performance - TipRanks

May 17, 2025
pulisher
May 16, 2025

VolitionRX (VNRX) Sees Revenue Growth and Cost Reduction in Q1 2 - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Transcript : VolitionRx Limited, Q1 2025 Earnings Call, May 16, 2025 - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: VolitionRx misses Q1 2025 earnings forecast - Investing.com

May 16, 2025
pulisher
May 16, 2025

Volitionrx Ltd earnings missed by $0.02, revenue fell short of estimates - Investing.com UK

May 16, 2025
pulisher
May 16, 2025

VolitionRX: Q1 Earnings Snapshot - CT Insider

May 16, 2025
pulisher
May 16, 2025

VolitionRx Q1 2025 Earnings Call Transcript - MarketBeat

May 16, 2025
pulisher
May 15, 2025

Volitionrx Ltd earnings missed by $0.03, revenue fell short of estimates - Investing.com South Africa

May 15, 2025

VolitionRX Ltd Azioni (VNRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$302.95
price up icon 1.50%
diagnostics_research DGX
$168.55
price down icon 1.95%
$138.90
price down icon 1.53%
diagnostics_research LH
$264.96
price down icon 1.02%
diagnostics_research MTD
$1,263.99
price up icon 0.26%
diagnostics_research A
$120.18
price down icon 0.14%
Capitalizzazione:     |  Volume (24 ore):